Publication: 2611

Publication: 2611

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Ann Oncol vol 28 (5) 1070-77

Year:: 2017
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 6

Parents:: 2360 2504
Children:: None

Program:: TRP
Primary Committee:: PPP
Sec. Committees:: Breast

Pharmas:
Grants:: K22CA188163, U10CA025224, U10CA037347, U10CA037404, U10CA047577, U10CA076001, U10CA077440, U10CA180790, U10CA180833, U10CA180857, U10CA180858, U10CA180870, U10CA180821, U10CA180882, U54HG003079

Corr. Author:
Authors:: R. Lesurf O. L. Griffith M. Griffith J. Hundal L. Trani M. A. Watson R. Aft M. J. Ellis D. Ota V. J. Suman F. Meric-Bernstam A. M. Leitch J. C. Boughey G. Unzeitig A. U. Buzdar K. K. Hunt E. R. Mardis

Networks:: LAPS-MN026, LAPS-MO011, LAPS-TX011, LAPS-TX035, TX041, TX190

Study: ACOSOG-Z1041
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: